NKTREUR Nektar Therapeutics

held by 1 manager in Q2 2017

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	1.22%	6 mo	Add 75.2%	$23M	1,166,100

Search